Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Botulinum toxin therapy for treatment of spasticity in multiple sclerosis: review and recommendations of the IAB-Interdisciplinary Working Group for Movement Disorders task force.
The efficacy and safety of teriflunomide based therapy in patients with relapsing multiple sclerosis: A meta-analysis of randomized controlled trials.
Real-World Outcomes in Fingolimod-Treated Patients with Multiple Sclerosis in the Czech Republic: Results from the 12-Month GOLEMS Study.
Survey of US Patients with Multiple Sclerosis: Comparison of the New Electronic Interferon Beta-1b Autoinjector (BETACONNECT™) With Mechanical Autoinjectors.
Angiotensin-(1-7) Protects from Brain Damage Induced by Shiga Toxin 2-Producing Enterohemorrhagic Escherichia Coli.
Healthy Life-Years Lost and Excess Bed-Days Due to 6 Patient Safety Incidents: Empirical Evidence From English Hospitals.
Poster 362 Osmotic Demyelination in Lyme Disease: A Case Report.
T cell cytokine signatures: Biomarkers in pediatric multiple sclerosis.
Improved Automatic Detection of New T2 Lesions in Multiple Sclerosis Using Deformation Fields.
Cryptococcal meningitis after fingolimod discontinuation in a patient with multiple sclerosis.
CSF neurofilament light: A universal risk biomarker in multiple sclerosis?
The Three Sisters of Fate in Multiple Sclerosis: Klotho (Clotho), Fibroblast Growth Factor-23 (Lachesis), and Vitamin D (Atropos).
Exercise and Alzheimer's Disease, Parkinson's Disease, and Multiple Sclerosis.
Plasticity Related Gene 3 (PRG3) overcomes myelin-associated growth inhibition and promotes functional recovery after spinal cord injury.
Glioblastoma multiforme of the optic chiasm: A rare case of common pathology.
Rescue effects of intravenous immunoglobulin on optic nerve degeneration in a rat model of neuromyelitis optica.
Fine specificity of the antibody response to Epstein-Barr nuclear antigen-2 and other Epstein-Barr virus proteins in patients with clinically isolated syndrome: A peptide microarray-based case-control study.
The dynamics of mucosal-associated invariant T cells in multiple sclerosis.
Serum Gelatinases Levels in Multiple Sclerosis Patients during 21 Months of Natalizumab Therapy.
A high throughput drug screening assay to identify compounds that promote oligodendrocyte differentiation using acutely dissociated and purified oligodendrocyte precursor cells.
Linc-MAF-4 regulates Th1/Th2 differentiation and is associated with the pathogenesis of multiple sclerosis by targeting MAF.
Treatment of spontaneous EAE by laquinimod reduces Tfh, B cell aggregates, and disease progression.
Dietary Interventions in Multiple Sclerosis: Development and Pilot-Testing of an Evidence Based Patient Education Program.
Tamoxifen accelerates the repair of demyelinated lesions in the central nervous system.
Ghrelin and adipose-derived mesenchymal stromal cells improve nerve regeneration in a rat model of epsilon-caprolactone conduit reconstruction.

Pages